Application 219117
- Type
- ANDA
- Sponsor
- LANNETT CO INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | SELEXIPAG | SELEXIPAG | TABLET | 1200UG | No | No |
| 003 | SELEXIPAG | SELEXIPAG | TABLET | 400UG | No | No |
| 004 | SELEXIPAG | SELEXIPAG | TABLET | 1000UG | No | No |
| 005 | SELEXIPAG | SELEXIPAG | TABLET | 1600UG | No | No |
| 006 | SELEXIPAG | SELEXIPAG | TABLET | 800UG | No | No |
| 007 | SELEXIPAG | SELEXIPAG | TABLET | 600UG | No | No |
| 008 | SELEXIPAG | SELEXIPAG | TABLET | 200UG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| UPTRAVI | SELEXIPAG | Actelion Pharmaceuticals US, Inc. | a7a23b87-f892-4e2c-8e2e-ebf841220f90 | 2026-05-28 | Warnings, Adverse reactions | SELEXIPAG |
| Selexipag | SELEXIPAG | Zydus Lifesciences Limited | ff660787-880f-4f2b-baac-fd2dbfcd79c2 | 2025-11-07 | Warnings, Adverse reactions | Selexipag SELEXIPAG |
| Selexipag | SELEXIPAG | Zydus Pharmaceuticals (USA) Inc. | c604e181-e336-4194-bf96-f65dd164d461 | 2024-05-25 | Warnings, Adverse reactions | Selexipag SELEXIPAG |